| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein |
|---|---|---|---|---|
| 10000631 | ADIAVPLVFTK | T | 10 | 31 |
| 10000632 | ESLAQPVSDSSK | S | 8 | 446 |
| 10009485 | ADIAVPLVFTK | T | 10 | 31 |
| 10009486 | ESLAQPVSDSSK | S | 8 | 446 |
| 10013720 | PSVQSSK | S | 381 | |
| 10013721 | PSVQSSK | S | 382 |
| ID | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Condition | log2Ratio | P Value | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|
| 10000631 | MS | HTP | unambiguous | human | brain | Alzheimers disease/control | -0.178850914 | 0.371346702 | 28657654 | |
| 10000632 | MS | HTP | unambiguous | human | brain | Alzheimers disease/control | 0.093080839 | 0.526621777 | 28657654 | |
| 10009485 | MS | HTP | unambiguous | human | brain | 28657654 | ||||
| 10009486 | MS | HTP | unambiguous | human | brain | 28657654 | ||||
| 10013720 | MS | HTP | unambiguous | human | HeLa cells | 30379171 | ||||
| 10013721 | MS | HTP | unambiguous | human | HeLa cells | 30379171 |
| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10000631 | ADIAVPLVFTK | T | 10 | 31 | MS | HTP | unambiguous | human | brain | 28657654 | |
| 10000632 | ESLAQPVSDSSK | S | 8 | 446 | MS | HTP | unambiguous | human | brain | 28657654 | |
| 10009485 | ADIAVPLVFTK | T | 10 | 31 | MS | HTP | unambiguous | human | brain | 28657654 | |
| 10009486 | ESLAQPVSDSSK | S | 8 | 446 | MS | HTP | unambiguous | human | brain | 28657654 | |
| 10013720 | PSVQSSK | S | 381 | MS | HTP | unambiguous | human | HeLa cells | 30379171 | ||
| 10013721 | PSVQSSK | S | 382 | MS | HTP | unambiguous | human | HeLa cells | 30379171 |